1474 related articles for article (PubMed ID: 34363717)
1. Herpes zoster after ChAdOx1 nCoV-19 vaccine: a case series.
Vastarella M; Picone V; Martora F; Fabbrocini G
J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):e845-e846. PubMed ID: 34363717
[No Abstract] [Full Text] [Related]
2. Herpes zoster following vaccination with ChAdOx1 nCoV-19 Coronavirus vaccine (recombinant).
Job AM; Sudhamani B; Mohan M; Mohanasundaram SN
Indian J Public Health; 2022; 66(1):83-85. PubMed ID: 35381724
[TBL] [Abstract][Full Text] [Related]
3. Herpes zoster viral infection after AZD1222 and BNT162b2 coronavirus disease 2019 mRNA vaccines: a case series.
Koumaki D; Krueger-Krasagakis SE; Papadakis M; Katoulis A; Koumaki V; Evangelou G; Stefanidou M; Mylonakis D; Zografaki K; Krasagakis K
J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):e85-e86. PubMed ID: 34606142
[No Abstract] [Full Text] [Related]
4. Herpes Zoster following SARS-CoV-2 vaccination - a series of four cases.
Alpalhão M; Filipe P
J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e750-e752. PubMed ID: 34310754
[No Abstract] [Full Text] [Related]
5. Herpes zoster after inactivated SARS-CoV-2 vaccine in two healthy young adults.
Özdemir AK; Kayhan S; Çakmak SK
J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):e846-e847. PubMed ID: 34363257
[No Abstract] [Full Text] [Related]
6. Herpes Zoster Reactivation After mRNA and Adenovirus-Vectored Coronavirus Disease 2019 Vaccination: Analysis of National Health Insurance Database.
Yoon JG; Kim YE; Choi MJ; Choi WS; Seo YB; Jung J; Hyun HJ; Seong H; Nham E; Noh JY; Song JY; Kim WJ; Kim DW; Cheong HJ
J Infect Dis; 2023 Nov; 228(10):1326-1335. PubMed ID: 37549237
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex encephalitis following ChAdOx1 nCoV-19 vaccination: a case report and review of the literature.
Moslemi M; Ardalan M; Haramshahi M; Mirzaei H; Sani SK; Dastgir R; Dastgir N
BMC Infect Dis; 2022 Mar; 22(1):217. PubMed ID: 35241013
[TBL] [Abstract][Full Text] [Related]
8. Herpes Zoster Following a Nucleoside-Modified Messenger RNA COVID-19 Vaccine.
Dezoteux F; Massip É; Marcant P; Sobaszek A; Chopin MC; Vuotto F; Staumont-Sallé D
Cutis; 2022 Jan; 109(1):E5-E7. PubMed ID: 35180059
[TBL] [Abstract][Full Text] [Related]
9. Can SARS-CoV-2 vaccine increase the risk of reactivation of Varicella zoster? A systematic review.
Desai HD; Sharma K; Shah A; Patoliya J; Patil A; Hooshanginezhad Z; Grabbe S; Goldust M
J Cosmet Dermatol; 2021 Nov; 20(11):3350-3361. PubMed ID: 34719084
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus retinitis following ChAdOx1 nCoV- 19 (Covishield) vaccination for SARS CoV 2: A case report.
Singh J; More A; Shetty SB; Chaskar P; Sen A
Ocul Immunol Inflamm; 2022 Jul; 30(5):1282-1285. PubMed ID: 35587646
[TBL] [Abstract][Full Text] [Related]
11. Hypothesis: Possible influence of antivector immunity and SARS-CoV-2 variants on efficacy of ChAdOx1 nCoV-19 vaccine.
Zamai L; Rocchi MBL
Br J Pharmacol; 2022 Jan; 179(2):218-226. PubMed ID: 34331459
[TBL] [Abstract][Full Text] [Related]
12. Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports.
Sah MK; Singh BM; Sinha P; Devkota P; Yadav SK; Shrestha J; Shrestha A
J Med Case Rep; 2022 May; 16(1):182. PubMed ID: 35524323
[TBL] [Abstract][Full Text] [Related]
13. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine.
Nasuelli NA; De Marchi F; Cecchin M; De Paoli I; Onorato S; Pettinaroli R; Savoini G; Godi L
Neurol Sci; 2021 Nov; 42(11):4747-4749. PubMed ID: 34272622
[TBL] [Abstract][Full Text] [Related]
14. A narrative review and clinical anatomy of herpes zoster infection following COVID-19 vaccination.
Iwanaga J; Fukuoka H; Fukuoka N; Yutori H; Ibaragi S; Tubbs RS
Clin Anat; 2022 Jan; 35(1):45-51. PubMed ID: 34554601
[TBL] [Abstract][Full Text] [Related]
15. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.
Krzywicka K; Heldner MR; Sánchez van Kammen M; van Haaps T; Hiltunen S; Silvis SM; Levi M; Kremer Hovinga JA; Jood K; Lindgren E; Tatlisumak T; Putaala J; Aguiar de Sousa D; Middeldorp S; Arnold M; Coutinho JM; Ferro JM
Eur J Neurol; 2021 Nov; 28(11):3656-3662. PubMed ID: 34293217
[TBL] [Abstract][Full Text] [Related]
16. Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine.
Rogawski McQuade ET; Breskin A
Lancet; 2021 Sep; 398(10304):933-935. PubMed ID: 34480860
[No Abstract] [Full Text] [Related]
17. ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant.
Struyf F; Sadoff J; Douoguih M
N Engl J Med; 2021 Aug; 385(6):571. PubMed ID: 34289270
[No Abstract] [Full Text] [Related]
18. Association study between herpes zoster reporting and mRNA COVID-19 vaccines (BNT162b2 and mRNA-1273).
Préta LH; Contejean A; Salvo F; Treluyer JM; Charlier C; Chouchana L
Br J Clin Pharmacol; 2022 Jul; 88(7):3529-3534. PubMed ID: 35174524
[TBL] [Abstract][Full Text] [Related]
19. ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant. Reply.
Madhi SA; Izu A; Pollard AJ
N Engl J Med; 2021 Aug; 385(6):571-572. PubMed ID: 34289271
[No Abstract] [Full Text] [Related]
20. Emergence of COVID-19 variants among ChAdOx1 nCoV-19 (recombinant) vaccine recipients.
Vaishya R; Sibal A; Singh SK; Malani A; Das S
Indian J Med Res; 2021 May; 153(5&6):559-561. PubMed ID: 34528522
[No Abstract] [Full Text] [Related]
[Next] [New Search]
